{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:05:31Z","timestamp":1791227131662,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"CONACYT"},{"name":"Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa en Enfermedades Cardiovasculares RECAVA"},{"DOI":"10.13039\/501100004837","name":"Ministry of Science and Innovation","doi-asserted-by":"crossref","award":["SAF2010-16037"],"award-info":[{"award-number":["SAF2010-16037"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004837","name":"Ministry of Science and Innovation","doi-asserted-by":"crossref","award":["SAF2012-39732"],"award-info":[{"award-number":["SAF2012-39732"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004837","name":"Ministry of Science and Innovation","doi-asserted-by":"crossref","award":["BFU2011-24760"],"award-info":[{"award-number":["BFU2011-24760"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"crossref","award":["P2010\/BMD-2378"],"award-info":[{"award-number":["P2010\/BMD-2378"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.biocel.2013.08.005","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T08:47:02Z","timestamp":1376556422000},"page":"2501-2511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma"],"prefix":"10.1016","volume":"45","author":[{"given":"Luis","family":"Castro-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Agra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Llorente Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Moti\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisardo","family":"Bosc\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Mart\u00edn-Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2013.08.005_bib0005","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1074\/jbc.M411221200","article-title":"15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer","volume":"280","author":"Backlund","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biocel.2013.08.005_bib0010","doi-asserted-by":"crossref","first-page":"9331","DOI":"10.1158\/0008-5472.CAN-08-2893","article-title":"Repression of 15-hydroxyprostaglandin dehydrogenase involves histone deacetylase 2 and snail in colorectal cancer","volume":"68","author":"Backlund","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.biocel.2013.08.005_bib0015","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1096\/fj.01-0158fje","article-title":"Contribution of cyclooxygenase 2 to liver regeneration after partial hepatectomy","volume":"15","author":"Casado","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.biocel.2013.08.005_bib0020","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1749-6632.2009.03701.x","article-title":"Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth","volume":"1155","author":"Cusimano","year":"2009","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.biocel.2013.08.005_bib0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbrc.2008.06.098","article-title":"COX-2 mediates hepatitis B virus X protein abrogation of p53-induced apoptosis","volume":"374","author":"Cheng","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biocel.2013.08.005_bib0030","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1593\/neo.91638","article-title":"Peroxisome proliferator-activated receptor-gamma inhibits transformed growth of non-small cell lung cancer cells through selective suppression of Snail","volume":"12","author":"Choudhary","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.biocel.2013.08.005_bib0035","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.1073\/pnas.95.15.8847","article-title":"Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas","volume":"95","author":"de La Coste","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biocel.2013.08.005_bib0040","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1042\/BJ20111052","article-title":"Involvement of PGE2 and the cAMP signalling pathway in the up-regulation of COX-2 and mPGES-1 expression in LPS-activated macrophages","volume":"443","author":"Diaz-Munoz","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.biocel.2013.08.005_bib0045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/carcin\/bgh277","article-title":"NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer","volume":"26","author":"Ding","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biocel.2013.08.005_bib0050","article-title":"EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity","author":"Donnini","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.biocel.2013.08.005_bib0055","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1124\/mol.106.033357","article-title":"Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase","volume":"71","author":"Hazra","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.biocel.2013.08.005_bib0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1158\/1940-6207.CAPR-07-0009","article-title":"Regulation of prostaglandin transporters in colorectal neoplasia","volume":"1","author":"Holla","year":"2008","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.biocel.2013.08.005_bib0065","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1158\/0008-5472.CAN-09-1089","article-title":"Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma","volume":"69","author":"Hoshida","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.biocel.2013.08.005_bib0070","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1158\/0008-5472.CAN-06-0325","article-title":"Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma","volume":"66","author":"Kern","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.biocel.2013.08.005_bib0075","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/carcin\/bgh110","article-title":"Cyclooxygenase-2 inhibitors suppress the growth of human hepatocellular carcinoma implants in nude mice","volume":"25","author":"Kern","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biocel.2013.08.005_bib0080","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1053\/jhep.2002.36125","article-title":"Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells","volume":"36","author":"Kern","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2013.08.005_bib0085","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/hep.510290355","article-title":"Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation","volume":"29","author":"Koga","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2013.08.005_bib0090","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/ng1481","article-title":"Application of comparative functional genomics to identify best-fit mouse models to study human cancer","volume":"36","author":"Lee","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.biocel.2013.08.005_bib0095","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1158\/1535-7163.MCT-09-0551","article-title":"Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2","volume":"8","author":"Lim","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.biocel.2013.08.005_bib0100","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3748\/wjg.v18.i10.1028","article-title":"15-PGDH is reduced and induces apoptosis and cell cycle arrest in gastric carcinoma","volume":"18","author":"Lou","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.biocel.2013.08.005_bib0105","article-title":"15-PGDH inhibits hepatocellular carcinoma growth through 15-keto-PGE\/PPARgamma-mediated activation of p21","author":"Lu","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.biocel.2013.08.005_bib0110","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.ajpath.2010.11.074","article-title":"Transgenic mice expressing cyclooxygenase-2 in hepatocytes reveal a minor contribution of this enzyme to chemical hepatocarcinogenesis","volume":"178","author":"Llorente Izquierdo","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.biocel.2013.08.005_bib0115","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/hep.22506","article-title":"Molecular targeted therapies in hepatocellular carcinoma","volume":"48","author":"Llovet","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2013.08.005_bib0120","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1158\/0008-5472.CAN-06-1787","article-title":"Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression","volume":"66","author":"Mann","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.biocel.2013.08.005_bib0125","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/sj.bjp.0702196","article-title":"Expression of cyclooxygenase-2 in foetal rat hepatocytes stimulated with lipopolysaccharide and pro-inflammatory cytokines","volume":"125","author":"Martin-Sanz","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biocel.2013.08.005_bib0130","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/carcin\/bgi022","article-title":"Prostaglandin E2 promotes migration and adhesion in hepatocellular carcinoma cells","volume":"26","author":"Mayoral","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biocel.2013.08.005_bib0135","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1093\/carcin\/bgp183","article-title":"HGF\/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells","volume":"30","author":"Moore","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biocel.2013.08.005_bib0140","doi-asserted-by":"crossref","first-page":"12098","DOI":"10.1073\/pnas.0603235103","article-title":"15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis","volume":"103","author":"Myung","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biocel.2013.08.005_bib0145","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.bcp.2011.08.005","article-title":"15-Hydroxyprostaglandin dehydrogenase as a novel molecular target for cancer chemoprevention and therapy","volume":"82","author":"Na","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.biocel.2013.08.005_bib0150","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1136\/gut.2003.038364","article-title":"Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection: role of viral core and NS5A proteins","volume":"53","author":"Nunez","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.biocel.2013.08.005_bib0155","doi-asserted-by":"crossref","first-page":"8885","DOI":"10.1073\/pnas.151217998","article-title":"Prostaglandins are required for CREB activation and cellular proliferation during liver regeneration","volume":"98","author":"Rudnick","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biocel.2013.08.005_bib0160","first-page":"123","article-title":"Disruption of the pRb\/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha","volume":"58","author":"Santoni-Rugiu","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.biocel.2013.08.005_bib0165","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1038\/onc.2011.472","article-title":"Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis","volume":"31","author":"Sasaki","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.biocel.2013.08.005_bib0170","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/pr.56.3.3","article-title":"Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition","volume":"56","author":"Simmons","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.biocel.2013.08.005_bib0175","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/07357907.2011.568562","article-title":"15-hydroxyprostaglandin dehydrogenase is downregulated and exhibits tumor suppressor activity in gastric cancer","volume":"29","author":"Song","year":"2011","journal-title":"Cancer Invest"},{"key":"10.1016\/j.biocel.2013.08.005_bib0180","doi-asserted-by":"crossref","first-page":"12647","DOI":"10.1074\/jbc.M312972200","article-title":"Microsomal prostaglandin E synthase-1 is overexpressed in inflammatory bowel disease. Evidence for involvement of the transcription factor Egr-1","volume":"279","author":"Subbaramaiah","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biocel.2013.08.005_bib0185","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10555-011-9314-z","article-title":"Prostaglandin catabolic enzymes as tumor suppressors","volume":"30","author":"Tai","year":"2011","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.biocel.2013.08.005_bib0190","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.prostaglandins.2011.06.005","article-title":"Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs)","volume":"96","author":"Tai","year":"2011","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.biocel.2013.08.005_bib0195","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2174\/138161206776055958","article-title":"NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions","volume":"12","author":"Tai","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.biocel.2013.08.005_bib0200","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.bcp.2006.06.004","article-title":"Histone deacetylase inhibitors and transforming growth factor-beta induce 15-hydroxyprostaglandin dehydrogenase expression in human lung adenocarcinoma cells","volume":"72","author":"Tong","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.biocel.2013.08.005_bib0205","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1210\/en.2003-1229","article-title":"Synergistic induction of the nicotinamide adenine dinucleotide-linked 15-hydroxyprostaglandin dehydrogenase by an androgen and interleukin-6 or forskolin in human prostate cancer cells","volume":"145","author":"Tong","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.biocel.2013.08.005_bib0210","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.abb.2004.11.031","article-title":"15-Hydroxyprostaglandin dehydrogenase can be induced by dexamethasone and other glucocorticoids at the therapeutic level in A549 human lung adenocarcinoma cells","volume":"435","author":"Tong","year":"2005","journal-title":"Arch Biochem Biophys."},{"key":"10.1016\/j.biocel.2013.08.005_bib0215","doi-asserted-by":"crossref","first-page":"7818","DOI":"10.1158\/0008-5472.CAN-05-4368","article-title":"15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer","volume":"66","author":"Wolf","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.biocel.2013.08.005_bib0220","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0016-5085(03)00904-1","article-title":"JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1","volume":"125","author":"Yamamoto","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biocel.2013.08.005_bib0225","doi-asserted-by":"crossref","first-page":"9409","DOI":"10.1073\/pnas.0902367106","article-title":"15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors","volume":"106","author":"Yan","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biocel.2013.08.005_bib0230","doi-asserted-by":"crossref","first-page":"17468","DOI":"10.1073\/pnas.0406142101","article-title":"15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers","volume":"101","author":"Yan","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biocel.2013.08.005_bib0235","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1158\/0008-5472.CAN-06-2287","article-title":"Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer","volume":"67","author":"Yang","year":"2007","journal-title":"Cancer Res"}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272513002586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272513002586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:54:42Z","timestamp":1761202482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272513002586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1357272513002586"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2013.08.005","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2013.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}